Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion type Assertion NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_head.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion description "[Dukes stages C and D were more frequent in primary tumors with loss of MSH3 expression (9 of 13), compared with tumors with retained expression (1 of 14; Fisher's exact test, P = 0.001), suggesting that MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_provenance.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion evidence source_evidence_literature NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_provenance.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion SIO_000772 14871813 NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_provenance.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion wasDerivedFrom befree-2016 NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_provenance.
- NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_assertion wasGeneratedBy ECO_0000203 NP431240.RA5T2iaDBXvvJGUXKOrxDZBt_wq3hi5jrDk3o_sOF7cEY130_provenance.